Appropriate therapy for fistulizing and fibrostenotic Crohn's disease: Results of a multidisciplinary expert panel - EPACT II

Journal of Crohn's and Colitis

Volumn 3, Issue 4, 2009, Pages 250-256

  Felley, Christian ^a   Vader, John Paul ^b   Juillerat, Pascal ^a,b   Pittet, Valérie ^b   O'Morain, Colm ^d   Panis, Yves ^e   Vucelic, Boris ^f   Gonvers, Jean Jacques ^a   Mottet, Christian ^a   Froehlich, Florian ^a,c   Michetti, Pierre ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF BASEL   (Switzerland)

^d ADELAIDE AND MEATH HOSPITAL   (Ireland)

^e BEAUJON HOSPITAL   (France)

^f KBC Zagreb   (Croatia)

Author keywords

Appropriateness; Crohn's disease; Fistulas; RAND Appropriateness Method; Stenosis

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; INFLIXIMAB; MERCAPTOPURINE; METHOTREXATE;

ARTICLE; BALLOON DILATATION; CROHN DISEASE; DRUG TREATMENT FAILURE; HUMAN; INTESTINE FISTULA; INTESTINE RESECTION; INTESTINE STENOSIS; PRIORITY JOURNAL;

EID: 70350581891     PISSN: 18739946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.crohns.2009.06.001     Document Type: Article

References (18)

1. Cosnes J., Cattan S., Blain A., et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 8 (2002) 244-250
2. Schwartz D.A., Loftus Jr. E.V., Tremaine W.J., et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 122 (2002) 875-880
3. Felley C., Mottet C., Juillerat P., et al. Fistulizing Crohn's disease. Digestion 76 (2007) 109-112
4. Froehlich F., Juillerat P., Mottet C., et al. Fibrostenotic Crohn's disease. Digestion 76 (2007) 113-115
5. Vader J., Froehlich F., Juillerat P., et al. Appropriate treatment for Crohn's disease: methodology and summary results of a multidisciplinary international expert panel approach - EPACT. Digestion 73 (2006) 237-248
6. Brook R., Chassin M., Fink A., Solomon D., Kosecoff J., and Park R. A method for the detailed assessment of the appropriateness of medical technologies. Int J Technol Assess Health Care 2 (1986) 53-63
7. Fitch K., Bernstein S., Aguilar M., et al. The RAND/UCLA Appropriateness Method User's manual. Rand Corp (2001)
8. Sandborn W., Fazio V., Feagan B., and Hanauer S. AGA technical review on perianal Crohn's disease. Gastroenterology 125 (2003) 1508-1530
9. Bernstein L.H., Frank M.S., Brandt L.J., and Boley S.J. Healing of perineal Crohn's disease with metronidazole. Gastroenterology 79 (1980) 357-365
10. Brandt L., Bernstein L., Boley S., and Frank M. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 83 (1982) 383-387
11. Turunen U., Farkkila M., Valtonen V., and Seppala K. Long-term outcome of ciprofloxacin treatment in severe perianal or fistulous Crohns-disease. Gastroenterology 104 (1993) A793-A793
12. Solomon M. Combination of ciprofloxacine and metronidazole in severe perianal Crohn's disease. Clin Invest Med S 15 (1992) A41
13. Mahadevan U., and JFMDHP. Fistula response to methotrexate in Crohn's disease: a case series. Aliment Pharmacol Ther 18 (2003) 1003-1008
14. Sands B., Van Deventer S., and Bernstein C. Long-term treatment of fistulas in patients with Crohn's disease: response to infliximab in ACCENT II trial through 54 weeks. Gastroenterology 122 (2002) A81
15. Caprilli R., Gassull M.A., Escher J.C., et al., for the European Crohn's and Colitis O. European evidence based consensus on the diagnosis and management of Crohn's disease: special situations. Gut 55 (2006) i36-i58
16. Clark M., Colombel J.-F., Feagan B.C., et al. American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology 133 (2007) 312-339
17. Sampietro G.M., Corsi F., Maconi G., et al. Prospective study of long-term results and prognostic factors after conservative surgery for small bowel Crohn's disease. Clin Gastroenterol Hepatol 7 (2009) 183-191 quiz 125
18. Carter M.J., Lobo A.J., and Travis S.P.L. Guidelines for the management of inflammatory bowel disease in adults. Gut 53 (2004) v1-16